The ability to make an accurate diagnosis at the time of treatment is crucial for many diseases. However, current standard diagnostic procedures can only be performed in specialised healthcare facilities. To bring diagnostic methods from a specialised laboratory to the point of treatment, many alternative methods have been proposed. One of them is surface-enhanced Raman scattering (SERS), which offers advantageous features such as high sensitivity in biotarget detection and higher accuracy. Here, we have developed an advanced SERS platform for the ultrasensitive, rapid and highly specific identification of tumour biomarkers in liquid biopsies. Our particular focus is on the detection of Thyroglobulin (Tg), the most important tumour biomarker for the diagnosis and prognosis of thyroid cancer. Specifically, SERS-active substrates fabricated by nanosphere lithography on chip or on tips of optical fiber (OF) were functionalized with Tg Capture antibodies. Gold nanoparticles were functionalized with Detection antibodies and conjugated with a Raman reporter. The sandwich assay platform was validated in the planar configuration and a detection limit of only 7 pg/ml was successfully achieved. The same approach has been successfully demonstrated on washout fluids from fine needle aspiration biopsies of cancer patients. Finally, the functionalization strategy was translated to the LOF-SERS platform and successfully used to detect Tg concentration. The proposed SERS-assisted immunoassay platform has proven to be highly versatile and can be used with both microfluidic chip POC devices and SERS-OF-based optrodes to perform sensitive, specific and rapid ex vivo assays for Tg detection in liquid intraoperative biopsies.

SERS biosensor for ultrasensitive detection of human Thyroglobulin

Quero G.;
2024-01-01

Abstract

The ability to make an accurate diagnosis at the time of treatment is crucial for many diseases. However, current standard diagnostic procedures can only be performed in specialised healthcare facilities. To bring diagnostic methods from a specialised laboratory to the point of treatment, many alternative methods have been proposed. One of them is surface-enhanced Raman scattering (SERS), which offers advantageous features such as high sensitivity in biotarget detection and higher accuracy. Here, we have developed an advanced SERS platform for the ultrasensitive, rapid and highly specific identification of tumour biomarkers in liquid biopsies. Our particular focus is on the detection of Thyroglobulin (Tg), the most important tumour biomarker for the diagnosis and prognosis of thyroid cancer. Specifically, SERS-active substrates fabricated by nanosphere lithography on chip or on tips of optical fiber (OF) were functionalized with Tg Capture antibodies. Gold nanoparticles were functionalized with Detection antibodies and conjugated with a Raman reporter. The sandwich assay platform was validated in the planar configuration and a detection limit of only 7 pg/ml was successfully achieved. The same approach has been successfully demonstrated on washout fluids from fine needle aspiration biopsies of cancer patients. Finally, the functionalization strategy was translated to the LOF-SERS platform and successfully used to detect Tg concentration. The proposed SERS-assisted immunoassay platform has proven to be highly versatile and can be used with both microfluidic chip POC devices and SERS-OF-based optrodes to perform sensitive, specific and rapid ex vivo assays for Tg detection in liquid intraoperative biopsies.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11695/141315
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact